Publication Type:

Journal Article


Scientific Reports, Volume 7, p.43271 (2017)



Animals, Antineoplastic Agents, Brain Neoplasms, Cell Line, Dacarbazine, Delayed-Action Preparations, Disease Models, Animal, Drug Carriers, Glioma, Humans, Nanofibers, Neoplasm Recurrence, Local, Rats, Wistar, Survival Analysis, temozolomide, Theranostic Nanomedicine


Localized and controlled delivery of chemotherapeutics directly in brain-tumor for prolonged periods may radically improve the prognosis of recurrent glioblastoma. Here, we report a unique method of nanofiber by fiber controlled delivery of anti-cancer drug, Temozolomide, in orthotopic brain-tumor for one month using flexible polymeric nano-implant. A library of drug loaded (20 wt%) electrospun nanofiber of PLGA-PLA-PCL blends with distinct in vivo brain-release kinetics (hours to months) were numerically selected and a single nano-implant was formed by co-electrospinning of nano-fiber such that different set of fibres releases the drug for a specific periods from days to months by fiber-by-fiber switching. Orthotopic rat glioma implanted wafers showed constant drug release (116.6 μg/day) with negligible leakage into the peripheral blood (<100 ng) rendering ~1000 fold differential drug dosage in tumor versus peripheral blood. Most importantly, implant with one month release profile resulted in long-term (>4 month) survival of 85.7% animals whereas 07 day releasing implant showed tumor recurrence in 54.6% animals, rendering a median survival of only 74 days. In effect, we show that highly controlled drug delivery is possible for prolonged periods in orthotopic brain-tumor using combinatorial nanofibre libraries of bulk-eroding polymers, thereby controlling glioma recurrence.

Cite this Research Publication

R. Ramachandran, Junnuthula, V. Reddy, G Gowd, S., Ashokan, A., Thomas, J., Peethambaran, R., Thomas, A., Unni, A. Kodakara K., Panikar, D., Shantikumar V Nair, and Dr. Manzoor K., “Theranostic 3-Dimensional Nano Brain-Implant for Prolonged and Localized Treatment of Recurrent Glioma”, Scientific Reports, vol. 7, p. 43271, 2017.

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat or click here to download the PDF file.